InnovationRx: Two Industry Veterans Aim To Accelerate The Path To Personalized Care

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 14 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 37%
  • Publisher: 59%

Ai 뉴스

Artificial Intelligence,Patrick Soon-Shiong,Covid

Alex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.

to learn more about the effectiveness of different types of treatments.. “And we see that one of the critical gates on that path is in clinical evidence generation.”

But there is one catch: right now, creating these cells into useful tissues is a laborious process that can cost hundreds of thousands, if not millions, of dollars per patient. This makes both research and the development of potential cures an expensive prospect.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 318. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인